Invited review: Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation

Journal of Applied Physiology

Volumn 90, Issue 3, 2001, Pages 1125-1136

  Hernandez, Olga M ^a   Housmans, Philippe R ^b   Potter, James D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Actin; Familial hypertrophic cardiomyopathy; Myocardium; Tropomyosin; Troponin

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE; CALCIUM ION; MYOSIN; TROPOMYOSIN; TROPONIN C;

ACTIN MYOSIN INTERACTION; ARTICLE; BINDING AFFINITY; CALCIUM SIGNALING; ENZYME ACTIVITY; FAMILIAL DISEASE; GENE MUTATION; HEART CONTRACTION; HEART MUSCLE RELAXATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE FORCE; MYOFILAMENT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUDDEN DEATH; THIN FILAMENT;

EID: 0035109415     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2001.90.3.1125     Document Type: Article

References (98)

1. The effects of phosphorylation of cardiac troponin-I on its interactions with actin and cardiac troponin-C
2. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis
3. Novel cardiac beta-myosin heavy chain gene missense mutations (R869C and R870C) that cause familial hypertrophic cardiomyopathy
4. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle α-Tm (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay
5. 2+ regulation of thin filament motility
6. Familial hypertrophic cardiomyopathy: From mutations to functional defects
7. A mutant Tm that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity
8. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population
9. Photochemical cross-linking between rabbit skeletal troponin subunits. Troponin I-troponin T interactions
10. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the α-tropomyosin gene
11. Late-onset hypertrophic cardiomyopathy caused by a mutation in the cardiac troponin T gene
12. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy
13. The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the β myosin heavy chains and the essential and regulatory light chains
14. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu→Val mutation and a 403Arg→Gln mutation
15. 2- and COOH-terminal regions of skeletal muscle troponin I
16. The troponin complex and regulation of muscle contraction
17. Troponin: Structure, properties, and mechanism of functioning
18. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy
19. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy
20. Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias
21. A molecular basis for familial hypertrophic cardiomyopathy: A beta cardiac myosin heavy chain gene missense mutation
22. Molecular switches in troponin
23. Effects of two familial hypertrophic cardiomyopathy-causing mutations on α-tropomyosin structure and function
24. Reconstitution of troponin activity from three protein components
25. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His β-cardiac myosin heavy chain mutation
26. Functional consequences of the deletion mutation ΔGlu160 in human cardiac troponin T
27. Roles for the troponin tail domain in thin filament assembly and regulation. A deletional study of cardiac troponin T
28. Homozygous mutation in cardiac troponin T: Implications for hypertrophic cardiomyopathy
29. Regulation of force and unloaded sliding speed in single thin filaments: Effects of regulatory proteins and calcium
30. 2+ by calcium electrode and aequorin luminescence
31. The cardiac β-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population
32. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy
33. A model for the function of the bisphosphorylated heart-specific troponin-I N-terminus
34. Familial hypertrophic cardiomyopathy caused by a novel α-tropomyosin mutation (Val95Ala) is associated with mild cardiac hypertrophy but a high incidence of sudden death
35. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
36. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy
37. Clinical manifestations of hypertrophic cardiomyopathy with mutations in the cardiac β-myosin heavy chain gene or cardiac troponin T gene
38. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene
39. Coupling calcium binding to troponin C and cross-bridge cycling in skinned cardiac cells
40. Thin filament proteins and thin filament-linked regulation of vertebrate muscle contraction
41. Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy
42. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy
43. Phenotypic variation of familial hypertrophic cardiomyopathy caused by the Phe(110)→Ile mutation in cardiac troponin T
44. 2- and COOH-terminal domains of troponin T. ATPase activation and binding to troponin I and troponin C
45. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility
46. 2+ and troponin I peptide binding to the E41A mutant of the N-domain of skeletal troponin C
47. Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant α-tropomyosins in adult cardiac myocytes
48. Mechanism of constant contractile efficiency under cooling inotropy of myocardium: Simulation
49. Abnormal contractile function in transgenic mice expressing an FHC-linked troponin T (179N) mutation
50. Sudden cardiac death in familial hypertrophic cardiomyopathy is associated with a novel mutation in the troponin I gene
51. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy
52. Sudden death due to troponin T mutations
53. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events
54. Functional consequences of a carboxyl terminal missense mutation Arg278Cys in human cardiac troponin T
55. 2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy
56. Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy
57. Altered regulatory function of two familial hypertrophic cardiomyopathy troponin T mutants
58. Mouse model of a familial hypertrophic cardiomyopathy mutation in α-tropomyosin manifests cardiac dysfunction
59. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy
60. Novel missense mutation in α-tropomyosin gene found in Japanese patients with hypertrophic cardiomyopathy
61. Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy
62. Effects of missense mutations Phe110Ile and Glu244Asp in human cardiac troponin T on force generation in skinned cardiac muscle fibers
63. 2+-stimulated MgATPase of reconstituted actomyosin S-1
64. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice
65. Calcium ion regulation of muscle contraction: The regulatory role of troponin T
66. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy
67. Troponin T: Genetics, properties and function
68. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle
69. 2+ regulation of muscle contraction
70. 2+ regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild-type protein
71. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy
72. Novel mutation in the α-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy
73. Structural interactions responsible for the assembly of the troponin complex on the muscle thin filament
74. 2+
75. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins
76. Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene
77. Separation and characterization of the two functional regions of troponin involved in muscle thin filament regulation
78. Troponin I, stunning, hypertrophy, and failure of the heart
79. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: Insights into disease pathogenesis and troponin function
80. 2+-regulation of skeletal muscle contraction
81. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy
82. Effect of Arg145Gly mutation in human cardiac troponin I on the ATPase activity of cardiac myofibrils
83. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy
84. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy
85. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2
86. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
87. Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy
88. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy
89. A de novo mutation in α-tropomyosin that causes hypertrophic cardiomyopathy
90. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy
91. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3
92. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy
93. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action
94. Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy
95. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations
96. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the α-tropomyosin gene
97. 2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy
98. 2+-specific sites of troponin C